These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24568519)
1. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR. Zhu Z; Wang CP; Zhang YF; Nie L Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells. Huang K; Chen J; Yang MS; Tang YJ; Pan F Cancer Biomark; 2017; 18(3):231-239. PubMed ID: 28085008 [TBL] [Abstract][Full Text] [Related]
3. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2. Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127 [TBL] [Abstract][Full Text] [Related]
4. miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin. Guo P; Xiong X; Zhang S; Peng D Oncol Rep; 2016 Dec; 36(6):3552-3558. PubMed ID: 27748936 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR). Wu D; Huang HJ; He CN; Wang KY Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675 [TBL] [Abstract][Full Text] [Related]
6. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells. Chen W; Yang Y; Chen B; Lu P; Zhan L; Yu Q; Cao K; Li Q J Neurooncol; 2014 Oct; 120(1):43-53. PubMed ID: 25139024 [TBL] [Abstract][Full Text] [Related]
7. miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism. Tang XY; Zheng W; Ding M; Guo KJ; Yuan F; Feng H; Deng B; Sun W; Hou Y; Gao L Drug Des Devel Ther; 2016; 10():571-83. PubMed ID: 26966351 [TBL] [Abstract][Full Text] [Related]
8. Roles of microRNA-22 in Suppressing Proliferation and Promoting Sensitivity of Osteosarcoma Cells via Metadherin-mediated Autophagy. Wang P; Zhao ZQ; Guo SB; Yang TY; Chang ZQ; Li DH; Zhao W; Wang YX; Sun C; Wang Y; Feng W Orthop Surg; 2019 Apr; 11(2):285-293. PubMed ID: 30932352 [TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy. Jiao G; Ren T; Guo W; Ren C; Yang K Tumour Biol; 2015 May; 36(5):3969-77. PubMed ID: 25577250 [TBL] [Abstract][Full Text] [Related]
10. MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR. Yu Z; Li N; Jiang K; Zhang N; Yao LL Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5867-5873. PubMed ID: 30280766 [TBL] [Abstract][Full Text] [Related]
11. MiR-199a-3p enhances cisplatin sensitivity of cholangiocarcinoma cells by inhibiting mTOR signaling pathway and expression of MDR1. Li Q; Xia X; Ji J; Ma J; Tao L; Mo L; Chen W Oncotarget; 2017 May; 8(20):33621-33630. PubMed ID: 28422725 [TBL] [Abstract][Full Text] [Related]
12. MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1. Xu S; Fu GB; Tao Z; OuYang J; Kong F; Jiang BH; Wan X; Chen K Oncotarget; 2015 Sep; 6(28):26457-71. PubMed ID: 26238185 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly. Zhang X; Huang L; Zhao Y; Tan W Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606 [TBL] [Abstract][Full Text] [Related]
14. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells. Liu GT; Huang YL; Tzeng HE; Tsai CH; Wang SW; Tang CH Cancer Lett; 2015 Feb; 357(2):476-87. PubMed ID: 25444917 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318 [TBL] [Abstract][Full Text] [Related]
16. Tumor Suppressive Role of miR-342-5p in Human Chondrosarcoma Cells and 3D Organoids. Veys C; Benmoussa A; Contentin R; Duchemin A; Brotin E; Lafont JE; Saintigny Y; Poulain L; Denoyelle C; Demoor M; Legendre F; Galéra P Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070455 [TBL] [Abstract][Full Text] [Related]
17. microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer. Wu K; Hu Y; Yan K; Qi Y; Zhang C; Zhu D; Liu D; Zhao S J Cell Physiol; 2020 Feb; 235(2):1247-1258. PubMed ID: 31267531 [TBL] [Abstract][Full Text] [Related]
18. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma. Lin Z; Song D; Wei H; Yang X; Liu T; Yan W; Xiao J J Cancer Res Clin Oncol; 2016 Jan; 142(1):239-46. PubMed ID: 26276504 [TBL] [Abstract][Full Text] [Related]
19. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes. Farhadi E; Zaker F; Safa M; Rezvani MR Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565 [TBL] [Abstract][Full Text] [Related]
20. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma. Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]